David P Schenkein is Director of REGENERON PHARMACEUTICALS, INC.. Currently has a direct ownership of 282 shares of REGN, which is worth approximately $208,116. The most recent transaction as insider was on Jan 02, 2024, when has been sold 42 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 282
0% 3M change
17.5% 12M change
Total Value Held $208,116

David P Schenkein Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 02 2024
BUY
Grant, award, or other acquisition
-
42 Added 12.96%
282 Common Stock
Sep 08 2023
BUY
Grant, award, or other acquisition
-
240 Added 50.0%
240 Common Stock

Also insider at

DNLI
Denali Therapeutics Inc. Healthcare
AGIO
AGIOS PHARMACEUTICALS, INC. Healthcare
PRME
Prime Medicine, Inc.
DPS

David P Schenkein

Director
South San Francisco, CA

Track Institutional and Insider Activities on REGN

Follow REGENERON PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells REGN shares.

Notify only if

Insider Trading

Get notified when an Regeneron Pharmaceuticals, Inc. insider buys or sells REGN shares.

Notify only if

News

Receive news related to REGENERON PHARMACEUTICALS, INC.

Track Activities on REGN